MX2020006628A - Activador de aldehido deshidrogenasa 2 (aldh2). - Google Patents

Activador de aldehido deshidrogenasa 2 (aldh2).

Info

Publication number
MX2020006628A
MX2020006628A MX2020006628A MX2020006628A MX2020006628A MX 2020006628 A MX2020006628 A MX 2020006628A MX 2020006628 A MX2020006628 A MX 2020006628A MX 2020006628 A MX2020006628 A MX 2020006628A MX 2020006628 A MX2020006628 A MX 2020006628A
Authority
MX
Mexico
Prior art keywords
sub
alkoxy group
formula
different
same
Prior art date
Application number
MX2020006628A
Other languages
English (en)
Spanish (es)
Inventor
Keigo Tanaka
Masayuki Miyano
Tasuku Ishida
Raku Shinkyo
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of MX2020006628A publication Critical patent/MX2020006628A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/67Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/68Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/73Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2020006628A 2018-01-31 2019-01-29 Activador de aldehido deshidrogenasa 2 (aldh2). MX2020006628A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018015512 2018-01-31
PCT/JP2019/002955 WO2019151241A1 (ja) 2018-01-31 2019-01-29 Aldh2活性化剤

Publications (1)

Publication Number Publication Date
MX2020006628A true MX2020006628A (es) 2020-09-14

Family

ID=67391231

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020006628A MX2020006628A (es) 2018-01-31 2019-01-29 Activador de aldehido deshidrogenasa 2 (aldh2).

Country Status (12)

Country Link
US (1) US10406126B2 (pt)
EP (1) EP3747862A1 (pt)
JP (1) JPWO2019151241A1 (pt)
KR (1) KR20200115474A (pt)
CN (1) CN111566082A (pt)
AU (1) AU2019214670A1 (pt)
BR (1) BR112020014237A2 (pt)
CA (1) CA3085992A1 (pt)
IL (1) IL275883A (pt)
MX (1) MX2020006628A (pt)
RU (1) RU2020121490A (pt)
WO (1) WO2019151241A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230295091A1 (en) 2020-11-02 2023-09-21 Alchemedicine, Inc. Compound, Aldehyde Dehydrogenase 2 Activating Agent, Pharmaceutical Composition, and Therapeutic and/or Prophylactic Drug
WO2023204292A1 (ja) * 2022-04-22 2023-10-26 株式会社アークメディスン 化合物、アルデヒドデヒドロゲナーゼ2活性化剤、医薬組成物、並びに治療及び/又は予防薬

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1181487A (en) * 1915-06-21 1916-05-02 Martin Sindell Portable truck.
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
EP2126574B1 (en) * 2007-03-08 2015-12-23 The Board of Trustees of the Leland Stanford Junior University Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
JP2012087116A (ja) 2010-09-21 2012-05-10 Ishihara Sangyo Kaisha Ltd ベンズアミド誘導体又はその塩、それらを含有する殺虫剤、殺ダニ剤、殺線虫剤又は殺土壌害虫剤
US9670162B2 (en) 2013-03-14 2017-06-06 The Board Of Trustees Of The Leland Stanford Junio Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof
US20230295091A1 (en) * 2020-11-02 2023-09-21 Alchemedicine, Inc. Compound, Aldehyde Dehydrogenase 2 Activating Agent, Pharmaceutical Composition, and Therapeutic and/or Prophylactic Drug

Also Published As

Publication number Publication date
WO2019151241A1 (ja) 2019-08-08
BR112020014237A2 (pt) 2020-12-08
US20190231720A1 (en) 2019-08-01
CA3085992A1 (en) 2019-08-08
RU2020121490A (ru) 2022-02-28
AU2019214670A1 (en) 2020-07-09
EP3747862A1 (en) 2020-12-09
CN111566082A (zh) 2020-08-21
JPWO2019151241A1 (ja) 2021-01-28
US10406126B2 (en) 2019-09-10
KR20200115474A (ko) 2020-10-07
IL275883A (en) 2020-08-31

Similar Documents

Publication Publication Date Title
MX2021005714A (es) Nuevos compuestos heterociclicos.
CR20220351A (es) Inhibidores de proteínas kras mutantes
PH12020500236A1 (en) Heterocyclic compund and use thereof
MX2021000795A (es) Compuestos heterociclicos para inhibir la actividad de shp2.
MX2022003401A (es) Compuesto de piridona fusionada y metodo de preparacion del mismo y uso del mismo.
MX2021008241A (es) Compuesto heterociclico y su uso.
MX2020009530A (es) Inhibidores de la o-glicoproteína-2-acetamido-2-desoxi-3-dglicopir anosidasa.
UA117151C2 (uk) N-ациліміногетероциклічні сполуки
TW200637539A (en) CTGF inhibitors
CR20220251A (es) Nuevos derivados de metilquinazolinona
MX2009011769A (es) Derivados de piridona como inhibidores de mapk p38a.
CR20220004A (es) Nuevos compuestos heterocíclicos
MX2020001615A (es) Compuestos de piridina sustituidos con azol.
CR20200652A (es) Compuestos que aumentan la actividad del proteosoma
MX2020006628A (es) Activador de aldehido deshidrogenasa 2 (aldh2).
CY1122477T1 (el) Παραγωγα πυριδο-οξαζινονης ως αναστολεις tnap
ZA202101487B (en) Novel compounds
MX2022000944A (es) Combinaciones, mezclas y composiciones fungicidas y usos de las mismas.
PH12019500875A1 (en) Pyridone compound as c-met inhibitor
PH12019500541A1 (en) Heterocyclic compound, and harmful-arthropod-controlling agent containing same
MX2020002505A (es) Compuestos heteroaromaticos sustituidos con cicloolefinas y su uso.
AP2002002466A0 (en) 3-heterocycliylpropanohydroxamic acid PCP INHIBITORS.
MX2021001904A (es) Formas solidas de benzoxaborol sustituido y composiciones de las mismas.
WO2018166993A3 (en) PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
MX2022005201A (es) Formulaciones de naftalimida dimerica.